Target intelligence / Profile preview

Ribosomal protein L18 pseudogene 1 (RPL18P1)

Target
RPL18P1
Molecular classification
Other (Pseudogene)
01

Overview

RPL18P1 (ribosomal protein L18 pseudogene 1) is a non-coding processed pseudogene related to the functional ribosomal protein L18 gene. Pseudogenes like RPL18P1 are remnants of gene duplication or retrotransposition events and typically lack the capacity to produce any functional protein. While the functional RPL18 protein forms part of the 60S large ribosomal subunit and is essential for ribosome activity and protein synthesis, RPL18P1 is a genomic sequence that no longer encodes a protein and is not known to have biological activity. There is no evidence that RPL18P1 serves as a drug target, has clinical significance, or encodes a product involved in disease. Pseudogenes are commonly found for ribosomal proteins due to their high expression and retrotransposition rates. Unlike the functional RPL18 gene, which is associated with protein synthesis and certain diseases such as Diamond-Blackfan anemia, RPL18P1 is non-functional. RPL18P1 should not be confused with RPL18 (ribosomal protein L18), which is a functional and essential protein. Some ribosomal protein pseudogenes have been speculated to play roles as noncoding RNAs in regulatory pathways, especially in immunity or cancer, but there is no direct evidence or mechanistic implication for RPL18P1 specifically.

Other names
RPL18_7_1361RPL18P1
02

Mechanism of action

None (not druggable; no known mechanism of action)

03

Biological functions

None (no known protein-coding function; does not encode a functional product)
04

Disease associations

None direct; however, the broader family of ribosomal protein pseudogenes is being investigated for potential regulatory RNA effects in pathways such as tumor immunity, but no direct disease implication is established for RPL18P1 itself
05

Safety considerations

None (not targeted by drugs)
06

Interacting drugs

None (no protein product, so there are no known interacting drugs)
07

Biomarkers

None (not used as a biomarker)

Beyond the preview

Go deeper on Ribosomal protein L18 pseudogene 1 (RPL18P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L18 pseudogene 1 (RPL18P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call